Israeli Cannibble Food-Tech and AIBotics Enter Israel with Global Partner KEENON Robotics
Rhea-AI Summary
AIBotics (OTC:AIBT) announced a partnership with Cannibble Food-Tech to deploy AI-powered service robots in Israel, targeting the country’s $13 billion food service and hospitality market and later expanding to North America, Latin America, and the Middle East. The agreement contemplates reciprocal exclusive distribution of KEENON Robotics’ service robots (DinerBot T8–T11, ButlerBot W3, KleenBot C30/C40), an initial three-year term with automatic renewals, and a potential future equity transaction subject to due diligence and board approvals. The move cites rising labor costs and a projected global service-robot market CAGR >20% to surpass $90 billion by decade-end.
Positive
- Targets Israel’s $13 billion food service and hospitality market
- Reciprocal exclusive distribution for KEENON service robot lineup
- Initial 3-year term with automatic renewals
- Plans to expand into North America, Latin America, and Middle East
Negative
- Partnership terms subject to definitive agreements and due diligence
- Potential equity transaction is non-binding and requires board approval
News Market Reaction – EHVVF
In the Jan 23 session, EHVVF declined 5.56%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Partnership targets Israel’s
MIAMI and ROSH HAAYIN, Israel, Jan. 23, 2026 (GLOBE NEWSWIRE) -- AIBotics Inc. (OTC: AIBT), a developer of AI-enhanced service robots and intelligent automation software, today announced a partnership with Cannibble Food-Tech Ltd. (CSE: PLCN), an Israel-based company with established commercial relationships across key service industries.
The partnership will accelerate the deployment of AI-powered service robots across food service, hospitality, and security markets, initially in Israel and subsequently in North America, Latin America, and the Middle East, with the companies serving as reciprocal exclusive distributors for each other’s robotic products and services, subject to definitive agreements.
The agreement enables AIBotics to expand its offerings through the distribution of KEENON Robotics’ advanced service robot portfolio, including:
- DinerBot series (T8, T9, T10, T11)
- ButlerBot W3
- KleenBot C30 and C40
The collaboration comes as global adoption of service robots accelerates, with the market projected to grow at a compound annual rate of more than
Rising labor costs and tighter margins are pushing operators toward automation, while retailers, healthcare providers, and transportation hubs such as airports are increasingly adopting service robots to enhance efficiency, improve customer experiences, and reduce staff burden. Entry into Israel also provides a strategic gateway to the Middle East, where smart city initiatives and infrastructure investment are driving growing demand for robotics solutions.
Israel has long been recognized as a global innovation hub, and the adoption of intelligent service robots is expected to play an increasingly important role in improving productivity, addressing labor shortages, and enhancing customer experiences across multiple sectors. By combining AIBotics’ AI-driven robotics platforms with Cannibble’s established industry relationships and regional presence, the alliance aims to support scalable automation solutions that can positively impact Israel’s economy while serving as a launchpad for international expansion.
Cannibble Food-Tech recently formed a Robot and AI Division for the Food and Hospitality Industry to market AI-enhanced robotic technologies for use in food service, hospitality, and security applications. AIBotics brings a portfolio of service robots and AI software designed to automate repetitive tasks, improve operational efficiency, and provide consistent, data-driven performance in real-world environments.
“This alliance represents a significant strategic step forward for AIBotics,” said Ben Kaplan, CEO of AIBotics. “Israel is a natural market for advanced service robotics, and Cannibble’s relationships and regional expertise position us to move quickly. Together, we believe service robots can help transform labor-intensive industries while contributing to economic growth and technological leadership.”
The partnership also includes a potential future equity transaction, subject to due diligence and board approvals, underscoring its long-term strategic intent. It has an initial three-year term with automatic renewals and reflects a shared commitment to innovation, commercialization, and the responsible deployment of AI-driven robotics solutions globally.
About AIBotics
AIBotics, Inc. develops and manages AI- and robotics-enhanced technologies designed to solve real-world challenges. Its flagship product, the Phill Robot™, is an AI-powered massage robot that delivers spa-quality recovery with IoT integration. The Company is also focused on the next generation of artificial intelligence, systems capable of making independent decisions, managing complex tasks, and achieving outcomes without direct human input. To accelerate this vision, AIBotics has partnered to co-develop a next-generation autonomous operating platform.
Blending hardware expertise with a growing AI software stack, AIBotics is positioning itself as a leader in personal robotics, healthcare, wellness, and hospitality. The Company is expanding e-commerce distribution and pilot programs for Phill while also investing in R&D for its intelligent assistant platform.
For more information on AIBotics, visit www.AIBotics.ai
About Cannibble Food-Tech Ltd.
Cannibble Food-Tech Ltd. is an innovative food-tech company that develops food and beverage products variously enhanced with alternative proteins. Cannibble has developed proprietary formulas for food and beverage products enhanced with alternative proteins targeted for the "Better-for-You" segment. For more information about Cannibble and its business, visit http://www.cannibble.world
Forward-Looking Statement Disclaimer
This press release contains “forward-looking statements” within the meaning of applicable securities legislation. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions, opinions and estimates of management and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the U.S. Food and Drug Administration and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise, except as required by applicable law.
For Media and Investor Relations, please contact:
David L. Kugelman
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp
Email:dk@atlcp.com
